Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 201

1.

Cushing Disease in a patient with Multiple Endocrine Neoplasia type 2B.

Kasturi K, Fernandes L, Quezado M, Eid M, Marcus L, Chittiboina P, Rappaport M, Stratakis CA, Widemann B, Lodish M.

J Clin Transl Endocrinol Case Rep. 2017 Jun;4:1-4. doi: 10.1016/j.jecr.2017.02.001.

PMID:
28435794
2.

SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.

Jochmanova I, Wolf KI, King KS, Nambuba J, Wesley R, Martucci V, Raygada M, Adams KT, Prodanov T, Fojo AT, Lazurova I, Pacak K.

J Cancer Res Clin Oncol. 2017 Aug;143(8):1421-1435. doi: 10.1007/s00432-017-2397-3. Epub 2017 Apr 3.

PMID:
28374168
3.

Leptomeningeal dissemination of a low-grade lumbar paraganglioma: case report.

Thomson N, Pacak K, Schmidt MH, Palmer CA, Salzman KL, Champine M, Schiffman JD, Cohen AL.

J Neurosurg Spine. 2017 Apr;26(4):501-506. doi: 10.3171/2016.10.SPINE16948. Epub 2017 Jan 27.

4.

Relevant Discordance Between 68Ga-DOTATATE and 68Ga-DOTANOC in SDHB-Related Metastatic Paraganglioma: Is Affinity to Somatostatin Receptor 2 the Key?

Janssen I, Wolf KI, Chui CH, Millo CM, Pacak K.

Clin Nucl Med. 2017 Mar;42(3):211-213. doi: 10.1097/RLU.0000000000001504.

PMID:
28033222
5.

Flushing in (neuro)endocrinology.

Hannah-Shmouni F, Stratakis CA, Koch CA.

Rev Endocr Metab Disord. 2016 Sep;17(3):373-380. Review.

6.

Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.

Därr R, Nambuba J, Del Rivero J, Janssen I, Merino M, Todorovic M, Balint B, Jochmanova I, Prchal JT, Lechan RM, Tischler AS, Popovic V, Miljic D, Adams KT, Prall FR, Ling A, Golomb MR, Ferguson M, Nilubol N, Chen CC, Chew E, Taïeb D, Stratakis CA, Fojo T, Yang C, Kebebew E, Zhuang Z, Pacak K.

Endocr Relat Cancer. 2016 Dec;23(12):899-908. Epub 2016 Sep 27.

PMID:
27679736
7.

Pheochromocytoma: The First Metabolic Endocrine Cancer.

Jochmanova I, Pacak K.

Clin Cancer Res. 2016 Oct 15;22(20):5001-5011.

PMID:
27742786
8.

Pathology of Human Pheochromocytoma and Paraganglioma Xenografts in NSG Mice.

Powers JF, Pacak K, Tischler AS.

Endocr Pathol. 2017 Mar;28(1):2-6. doi: 10.1007/s12022-016-9452-5.

9.

The Author's Reply: inappropriate adrenoreceptor blockade prior to pheochromocytoma removal - 'A timely reappraisal'.

Luiz HV, Yu R, Wolf K, Miao N, Mannes A, Pacak K.

Clin Endocrinol (Oxf). 2016 Dec;85(6):990-991. doi: 10.1111/cen.13234. Epub 2016 Oct 3. No abstract available.

10.

A patient with MEN1 typical features and MEN2-like features.

El-Maouche D, Welch J, Agarwal SK, Weinstein LS, Simonds WF, Marx SJ.

Int J Endocr Oncol. 2016 May;3(2):89-95. Epub 2016 Apr 8.

11.

HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma.

Zhuang Z, Yang C, Ryska A, Ji Y, Hou Y, Graybill SD, Bullova P, Lubensky IA, Klöppel G, Pacak K.

Endocr Relat Cancer. 2016 May;23(5):L13-6. doi: 10.1530/ERC-16-0148. Epub 2016 Apr 29. No abstract available.

12.

Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.

Luiz HV, Tanchee MJ, Pavlatou MG, Yu R, Nambuba J, Wolf K, Prodanov T, Wesley R, Adams K, Fojo T, Pacak K.

Clin Endocrinol (Oxf). 2016 Jul;85(1):62-9. doi: 10.1111/cen.13066. Epub 2016 Apr 15.

13.

Mass spectrometric quantification of salivary metanephrines-A study in healthy subjects.

Osinga TE, van der Horst-Schrivers AN, van Faassen M, Kerstens MN, Dullaart RP, Pacak K, Links TP, Kema IP.

Clin Biochem. 2016 Sep;49(13-14):983-8. doi: 10.1016/j.clinbiochem.2016.02.003. Epub 2016 Feb 10.

14.

Rapidly Growing Chest Wall Mass in a Case of Sporadic Metastatic Paraganglioma: Imaging With 4 Different PET Radiopharmaceuticals.

Janssen I, Xekouki P, Nambuba J, Chen CC, Herscovitch P, Millo CM, Schrump DS, Pacak K.

Clin Nucl Med. 2016 May;41(5):399-400. doi: 10.1097/RLU.0000000000001116.

15.

Pituitary gigantism: update on molecular biology and management.

Lodish MB, Trivellin G, Stratakis CA.

Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):72-80. doi: 10.1097/MED.0000000000000212. Review.

16.

68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.

Janssen I, Chen CC, Taieb D, Patronas NJ, Millo CM, Adams KT, Nambuba J, Herscovitch P, Sadowski SM, Fojo AT, Buchmann I, Kebebew E, Pacak K.

J Nucl Med. 2016 Feb;57(2):186-91. doi: 10.2967/jnumed.115.161018. Epub 2015 Nov 12.

17.

Radiopharmaceuticals in paraganglioma imaging: too many members on board?

Taïeb D, Hicks RJ, Pacak K.

Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):391-3. doi: 10.1007/s00259-015-3213-4. Epub 2015 Oct 13. No abstract available.

18.

18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.

Blanchet EM, Taieb D, Millo C, Martucci V, Chen CC, Merino M, Herscovitch P, Pacak K.

J Nucl Med. 2015 Dec;56(12):1849-54. doi: 10.2967/jnumed.115.159061. Epub 2015 Sep 10.

19.

Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics.

Varoquaux A, le Fur Y, Imperiale A, Reyre A, Montava M, Fakhry N, Namer IJ, Moulin G, Pacak K, Guye M, Taïeb D.

Endocr Relat Cancer. 2015 Aug;22(4):M1-8. doi: 10.1530/ERC-15-0246. Epub 2015 Jun 26.

20.

Determination of the unmetabolised (18)F-FDG fraction by using an extension of simplified kinetic analysis method: clinical evaluation in paragangliomas.

Barbolosi D, Hapdey S, Battini S, Faivre C, Mancini J, Pacak K, Farman-Ara B, Taïeb D.

Med Biol Eng Comput. 2016 Jan;54(1):103-11. doi: 10.1007/s11517-015-1318-3. Epub 2015 Jun 5.

Supplemental Content

Loading ...
Support Center